Harbin Pharmaceutical Group

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
Harbin Pharmaceutical Group Co., Ltd.
Simplified Chinese 哈药集团股份有限公司
Traditional Chinese 哈藥集團股份有限公司
Literal meaning Harbin Pharmaceutical Group, Company Limited by Shares

Harbin Pharmaceutical Group Co., Ltd. (SSE: 600664) is China's second-biggest drug maker by market value.[1] The major shareholder of the company was Chinese: 哈药集团有限公司 for 47.06% stake (as at 30 June 2016), literally have the same English name with the listed subsidiary, as the listed subsidiary missed the word "Joint-Stock / Shares" (Chinese: 股份) in its English official name.


Harbin Pharmaceutical Group Sixth Pharmaceutical Factory

Harbin Pharmaceutical is engaged in the research, development, manufacture and sale of pharmaceutical products. The Company primarily offers antibiotics, Chinese patent medicines, over-the-counter (OTC) medicines, healthcare products and synthesized preparations, among others.

During the year ended December 31, 2007, the Company obtained approximately 73% and 14% of its total revenue from the sale of western medicines and traditional Chinese medicines, respectively. As of December 31, 2007, the Company had two subsidiaries/associates: one specializes in manufacturing oral solutions, while the other is engaged in the retail and wholesale of pharmaceuticals.


External links[edit]